Market Overview:
The global hydroxytryptamine receptor market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of psychiatric disorders, attention deficit hyperactivity disorder (ADHD), and Alzheimer’s disease. Additionally, growing awareness about the benefits of hydroxytryptamine receptors for treating various diseases is also contributing to the growth of this market. The global hydroxytryptamine receptor market is segmented on the basis of type, application, and region. On the basis of type, it is divided into HTR6, HTR2B, and others. The application segment includes psychiatric disorders such as depression and anxiety; ADHD; Alzheimer’s disease; chronic obstructive pulmonary disease (COPD); memory impairment; and others such as migraines and obesity. Geographically, it is analyzed across North America, Latin America, Europe Asia Pacific ,and Middle East & Africa .
Product Definition:
A hydroxytryptamine receptor is a type of receptor that binds to the neurotransmitter serotonin, also known as 5-hydroxytryptamine (5-HT). These receptors are found throughout the body, and are responsible for mediating many important physiological processes.
HTR6:
Hydroxytryptamine (HT) receptor is a G protein-coupled receptor that is found in the brain and other organs. It plays an important role in controlling sleep, memory, cardiovascular function, body temperature regulation and pain sensation.
HTR2B:
Hydroxytryptamine (HT) receptor 2B is a protein-based molecular target for hydroxytryptamine (HT). It is also known as KAI or Orexin receptor 2B. The HT2B receptors are G protein-coupled receptors with seven transmembrane domains and two intracytoplasmic loops.
Application Insights:
The application segment includes attention deficit hyperactivity disorder (ADHD), anxiety disorders, depression, bipolar disorder, multiple sclerosis and others. The market for hydroxytryptamine receptor is anticipated to witness significant growth owing to the increasing prevalence of mental disorders coupled with rising awareness among individuals regarding treatment options. According to a study published in NCBI in 2018 by researchers from China and India; it was found that around 1% of children between 6 months to 6 years have some symptoms of ADHD which goes away by itself without any treatment. However, 0.5% persists into adulthood leading to low productivity at work and school as well as high healthcare costs due largely less productive workforce due largely less productive workforce owing largely untreated ADHD during childhood & adolescence stage.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period owing to increasing awareness about mental health and availability of effective treatment for various disorders, such as attention deficit hyperactivity disorder (ADHD), bipolar disorder, anxiety, OCD, schizophrenia and others. Moreover, high disposable income of consumers in this region is anticipated to fuel demand for recreational drugs among individuals aged 13-18 years.
Asia Pacific hydroxytryptamine receptor market is expected to grow at a lucrative rate over the forecast period owing to rising prevalence of mental disorders coupled with growing awareness about available treatments in emerging economies including China and India. In addition, increasing number of clinical trials by local companies for evaluating efficacy & safety of Hydroxytyroid hormone will boost growth further.
Growth Factors:
- Increasing demand for antidepressants owing to rising cases of depression and anxiety disorders
- Growing geriatric population susceptible to neuropsychiatric disorders
- Rising awareness about the benefits of hydroxytryptamine receptor agonists and antagonists
- Technological advancements in hydroxytryptamine receptor research field
- Growing investments by pharmaceutical companies in R&D of new hydroxytryptamine receptor drugs
Scope Of The Report
Report Attributes
Report Details
Report Title
Hydroxytryptamine Receptor Market Research Report
By Type
HTR6, HTR2B, Others
By Application
Attention Deficit Hyperactivity Disorder, Psychiatric Disorders, Alzheimers Disease, Chronic Obstructive Pulmonary Disease, Memory Impairment
By Companies
Adamed, Avineuro Pharmaceutical, Axovant Sciences, Biotie Therapies, Celon Pharma, Galenea Corp, H. Lundbeck, Reviva Pharmaceuticals, Suven Life Sciences, Teva Pharmaceutical Industries Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
227
Number of Tables & Figures
159
Customization Available
Yes, the report can be customized as per your need.
Global Hydroxytryptamine Receptor Market Report Segments:
The global Hydroxytryptamine Receptor market is segmented on the basis of:
Types
HTR6, HTR2B, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Attention Deficit Hyperactivity Disorder, Psychiatric Disorders, Alzheimers Disease, Chronic Obstructive Pulmonary Disease, Memory Impairment
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Adamed
- Avineuro Pharmaceutical
- Axovant Sciences
- Biotie Therapies
- Celon Pharma
- Galenea Corp
- H. Lundbeck
- Reviva Pharmaceuticals
- Suven Life Sciences
- Teva Pharmaceutical Industries Ltd
Highlights of The Hydroxytryptamine Receptor Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- HTR6
- HTR2B
- Others
- By Application:
- Attention Deficit Hyperactivity Disorder
- Psychiatric Disorders
- Alzheimers Disease
- Chronic Obstructive Pulmonary Disease
- Memory Impairment
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Hydroxytryptamine Receptor Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
The hydroxytryptamine receptor is a type of protein that responds to the neurotransmitter serotonin. Serotonin is a chemical messenger that helps control mood, sleep, appetite, and other activities in the brain.
Some of the major players in the hydroxytryptamine receptor market are Adamed, Avineuro Pharmaceutical, Axovant Sciences, Biotie Therapies, Celon Pharma, Galenea Corp, H. Lundbeck, Reviva Pharmaceuticals, Suven Life Sciences, Teva Pharmaceutical Industries Ltd.
The hydroxytryptamine receptor market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Hydroxytryptamine Receptor Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Hydroxytryptamine Receptor Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Hydroxytryptamine Receptor Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Hydroxytryptamine Receptor Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Hydroxytryptamine Receptor Market Size & Forecast, 2020-2028
4.5.1 Hydroxytryptamine Receptor Market Size and Y-o-Y Growth
4.5.2 Hydroxytryptamine Receptor Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 HTR6
5.2.2 HTR2B
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Attention Deficit Hyperactivity Disorder
6.2.2 Psychiatric Disorders
6.2.3 Alzheimers Disease
6.2.4 Chronic Obstructive Pulmonary Disease
6.2.5 Memory Impairment
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Hydroxytryptamine Receptor Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Hydroxytryptamine Receptor Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 HTR6
9.6.2 HTR2B
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Attention Deficit Hyperactivity Disorder
9.10.2 Psychiatric Disorders
9.10.3 Alzheimers Disease
9.10.4 Chronic Obstructive Pulmonary Disease
9.10.5 Memory Impairment
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 HTR6
10.6.2 HTR2B
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Attention Deficit Hyperactivity Disorder
10.10.2 Psychiatric Disorders
10.10.3 Alzheimers Disease
10.10.4 Chronic Obstructive Pulmonary Disease
10.10.5 Memory Impairment
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 HTR6
11.6.2 HTR2B
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Attention Deficit Hyperactivity Disorder
11.10.2 Psychiatric Disorders
11.10.3 Alzheimers Disease
11.10.4 Chronic Obstructive Pulmonary Disease
11.10.5 Memory Impairment
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 HTR6
12.6.2 HTR2B
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Attention Deficit Hyperactivity Disorder
12.10.2 Psychiatric Disorders
12.10.3 Alzheimers Disease
12.10.4 Chronic Obstructive Pulmonary Disease
12.10.5 Memory Impairment
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 HTR6
13.6.2 HTR2B
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Attention Deficit Hyperactivity Disorder
13.10.2 Psychiatric Disorders
13.10.3 Alzheimers Disease
13.10.4 Chronic Obstructive Pulmonary Disease
13.10.5 Memory Impairment
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Hydroxytryptamine Receptor Market: Competitive Dashboard
14.2 Global Hydroxytryptamine Receptor Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Adamed
14.3.2 Avineuro Pharmaceutical
14.3.3 Axovant Sciences
14.3.4 Biotie Therapies
14.3.5 Celon Pharma
14.3.6 Galenea Corp
14.3.7 H. Lundbeck
14.3.8 Reviva Pharmaceuticals
14.3.9 Suven Life Sciences
14.3.10 Teva Pharmaceutical Industries Ltd
